S

Sharon Bio-Medicine

SHARONBIO

Tapetide Score

Data-driven rating, 0–100. How it works →

Growth Rate

Revenue Growth
4% level than 3Y
Net Income Growth
8% higher than 3Y

Quarterly Results

Particulars Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023
Sales
45.79
35.8
43.25
45.24
48.57
48.89
45.37
44.36
49.77
37.84
55.16
57.75
44.23
Expenses
37.71
31.81
38.6
38.72
42.11
42.27
38.52
38.01
43.4
36.99
44.46
47.46
40.72
Operating Profit
8.08
3.99
4.65
6.52
6.46
6.62
6.85
6.35
6.37
0.85
10.7
10.29
3.51
OPM %
17.65%
11.15%
10.75%
14.41%
13.3%
13.54%
15.1%
14.31%
12.8%
2.25%
19.4%
17.82%
7.94%
Other Income
0.49
0.38
0.64
1.01
2.08
0.66
0.47
0.56
1.13
0.72
0.85
2.09
0.79
Interest
0.04
0.04
0.04
0.05
0.04
0.03
0.03
0.03
0.02
0.02
0.02
0.01
0.01
Depreciation
2.5
2.83
2.88
2.91
2.89
2.76
2.82
2.85
2.8
2.66
2.69
2.91
2.49
PBT
6.03
1.5
2.37
4.57
5.61
4.49
4.47
4.03
4.68
-1.11
8.84
9.46
1.8
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
6.03
1.5
2.37
4.56
5.61
4.49
4.48
4.02
4.68
-1.11
8.85
9.47
1.81
EPS in Rs
0.51
0.13
0.2
0.38
0.47
0.38
0.38
0.34
0.39
-0.09
0.74
0.8
0.15
Figures in ₹ Crores

Profit & Loss

Particulars Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016 9mMar 2020Mar 2021Mar 2022Mar 2023
Sales
420
496
606
785
1,060
1,314
834
253
171
173
188
195
Expenses
381
445
535
690
939
1,157
868
387
145
151
162
170
Operating Profit
39
52
71
95
120
157
-34
-134
26
22
26
25
OPM %
9%
10%
12%
12%
11%
12%
-4.1%
-53%
15%
13%
14%
13%
Other Income
2
0
1
1
1
2
-74
-69
-72
4
3
4
Interest
14
21
27
34
43
59
94
71
0
0
0
0
Depreciation
4
6
8
9
12
15
19
15
11
12
11
11
PBT
22
24
36
53
66
85
-221
-289
-56
14
18
19
Tax %
16%
22%
15%
22%
20%
18%
2%
3%
0%
0%
0%
0%
Net Profit
19
19
31
42
53
70
-226
-299
-56
14
18
19
EPS in Rs
1.76
1.77
2.95
3.94
5.01
6.59
-18.99
-25.16
-4.75
1.18
1.49
1.6
Div. Payout %
7%
8%
6%
5%
3%
5%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023
Equity Capital
11
11
11
11
11
21
24
24
24
1
1
1
Reserves
96
112
188
182
233
323
94
-205
-664
-627
-610
-592
Borrowings
262
343
344
508
644
725
824
836
828
828
828
828
Other Liabilities
29
35
44
74
84
92
69
68
88
88
80
76
Total Liabilities
397
501
586
774
972
1,162
1,012
723
276
290
299
313
Fixed Assets
56
184
181
201
272
325
332
319
149
141
135
128
CWIP
107
23
27
60
43
15
0
0
0
0
0
0
Investments
1
4
4
4
4
1
1
0
0
0
0
0
Other Assets
233
290
374
509
654
820
678
404
128
149
164
185
Total Assets
397
501
586
774
972
1,162
1,012
723
276
290
299
313
Figures in ₹ Crores

Cash Flow

Particulars Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023
Operating
-50
-28
-36
-53
-70
-69
-82
-28
35
4
23
41
Investing
-66
-51
-8
-61
-64
-27
-10
0
-7
-4
-3
-3
Financing
47
78
46
117
134
103
96
22
0
0
0
0
Net Cash Flow
-69
-1
1
2
0
6
4
-6
28
0
20
38
Free Cash Flow
-121
-78
-46
-115
-135
-101
-93
-30
27
0
18
36
CFO/OP
-129
-55
-51
-56
-58
-44
238
21
133
19
86
160
Figures in ₹ Crores

Ratios

Particulars Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days
116
117
116
121
122
115
138
264
47
62
52
49
Inventory Days
90
102
112
109
105
106
136
198
173
209
162
149
Days Payable
23
23
23
28
24
20
23
44
214
183
167
155
Cash Conversion Cycle
183
195
205
202
203
201
251
418
7
88
48
43
Working Capital Days
176
188
72
78
72
79
129
68
-566
-514
-464
-474
ROCE %
11%
11%
13%
14%
14%
15%
-5%
-17%
—
7%
8%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sharon Bio-Medicine insights

56 extracted metrics + investor summaries across FY05–FY23.

Log in — free

Shareholding Pattern

Public99.98%DIIs0.02%As ofMar 2023

Documents

Frequently Asked Questions about Sharon Bio-Medicine

What does Sharon Bio-Medicine Ltd do?
Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.
Which sector does Sharon Bio-Medicine Ltd belong to?
Sharon Bio-Medicine Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.

Website sharonbio.com
Face Value ₹ 2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHARONBIO.md for Sharon Bio-Medicine Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List